These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 8671850)
1. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load. Garini G; Mazzi A; Buzio C; Mutti A; Allegri L; Savazzi G; Borghetti A Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850 [TBL] [Abstract][Full Text] [Related]
2. Renal effects of nifedipine and captopril in patients with essential hypertension and reduced renal reserve. Buzio C; Regolisti G; Perazzoli F; Mutti A; Bergamaschi E; Borghetti A Hypertension; 1994 Dec; 24(6):763-9. PubMed ID: 7995635 [TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease. Kloke HJ; Wetzels JF; Koene RA; Huysmans FT Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641 [TBL] [Abstract][Full Text] [Related]
4. Acute haemodynamic and proteinuric effects of prednisolone in patients with a nephrotic syndrome. Reichert LJ; Koene RA; Wetzels JF Nephrol Dial Transplant; 1999 Jan; 14(1):91-7. PubMed ID: 10052484 [TBL] [Abstract][Full Text] [Related]
5. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. Perico N; Remuzzi A; Sangalli F; Azzollini N; Mister M; Ruggenenti P; Remuzzi G J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785 [TBL] [Abstract][Full Text] [Related]
6. Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action. Heeg JE; de Jong PE; de Zeeuw D Clin Sci (Lond); 1991 Sep; 81(3):367-72. PubMed ID: 1655338 [TBL] [Abstract][Full Text] [Related]
7. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study. Jenkins DA; Cowan P; Patrick AW; Clarke BF Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284 [TBL] [Abstract][Full Text] [Related]
8. Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients. Giordano M; Sanders LR; Castellino P; Canessa ML; DeFronzo RA Nephron; 1996; 72(3):447-53. PubMed ID: 8852495 [TBL] [Abstract][Full Text] [Related]
9. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263 [TBL] [Abstract][Full Text] [Related]
10. The natriuretic effect of nifedipine gastrointestinal therapeutic system remains despite the presence of mild-to-moderate renal failure. Campo C; Garcia-Vallejo O; Barrios V; Lahera V; Manero M; Esteban E; Rodicio JL; Ruilope LM J Hypertens; 1997 Dec; 15(12 Pt 2):1803-8. PubMed ID: 9488243 [TBL] [Abstract][Full Text] [Related]
11. Comparison of converting enzyme inhibitor and calcium channel blocker in SHR with nephrotoxic serum nephritis. Ohno A; Inagaki C; Honda K; Sugino N Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):405-10. PubMed ID: 1635285 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Romero R; Salinas I; Lucas A; Teixidó J; Audi L; Sanmarti A Diabetes Res Clin Pract; 1992 Sep; 17(3):191-8. PubMed ID: 1425158 [TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of acute angiotensin converting enzyme inhibitors and calcium antagonists in transplant renal artery stenosis. Mourad G; Ribstein J; Argiles A; Mimran A; Mion C Nephrol Dial Transplant; 1989; 4(1):66-70. PubMed ID: 2494601 [TBL] [Abstract][Full Text] [Related]
14. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril. Townend JN; Doran J; Lote CJ; Davies MK Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658 [TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol. Böhler J; Becker A; Reetze-Bonorden P; Woitas R; Keller E; Schollmeyer P Eur J Clin Pharmacol; 1993; 44 Suppl 1():S57-61. PubMed ID: 8486148 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans. Golbetz H; Black V; Shemesh O; Myers BD Am J Physiol; 1989 Jan; 256(1 Pt 2):F44-51. PubMed ID: 2463770 [TBL] [Abstract][Full Text] [Related]
17. Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Heeg JE; de Jong PE; Vriesendorp R; de Zeeuw D Am J Nephrol; 1990; 10 Suppl 1():94-7. PubMed ID: 2175149 [TBL] [Abstract][Full Text] [Related]
18. Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease. Hemmelder MH; de Zeeuw D; de Jong PE Nephrol Dial Transplant; 1999 Jan; 14(1):98-104. PubMed ID: 10052485 [TBL] [Abstract][Full Text] [Related]
19. Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients? Pritchard G; Lyons D; Webster J; Petrie JC; MacDonald TM Br J Clin Pharmacol; 1997 Aug; 44(2):145-9. PubMed ID: 9278199 [TBL] [Abstract][Full Text] [Related]
20. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]